Skip to main content

Pairings: Aug 10, 2011

Premium

The National Institutes of Health has tapped Mahendra Rao to be director of the new Intramural Center for Regenerative Medicine (CRM). Rao formerly was VP of regenerative medicine at Life Technologies and he co-founded the neural stem cell company Q-Therapeutics. The NIH-CRM is an initiative to create a center of excellence in stem cell technology located at NIH's campus that will focus on studying and using induced pluripotent stem cells.

Rao had joined Life Tech predecessor Invitrogen in 2006 after serving as section chief for stem cells and senior investigator in the laboratory of neuroscience for the National Institute on Aging.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.